The protocol for immunohistochemical procedures of TLR2, CD38, CD68 and CD83 have been standardized and the expression of each cell marker (TLR2, CD38, CD68 and CD83) within refractory periapical granuloma was identified. This evidence concerns the gene CD38 and periapical granuloma.